Takeda Pharmaceutical
TAK
#467
Rank
C$72.28 B
Marketcap
C$22.88
Share price
-0.03%
Change (1 day)
19.57%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): C$4.49 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.86 Billion. , an increase over its 2024 earnings that were of C$3.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 C$4.57 B49.03%
2024 C$3.07 B-2.41%
2023 C$3.14 B-28.14%
2022 C$4.37 B-40.9%
2021 C$7.40 B78.24%
2020 C$4.15 B246.1%
2019 C$1.20 B-48.79%
2018 C$2.34 B-23.64%
2017 C$3.07 B21.7%
2016 C$2.52 B-253.01%
2015 -C$1.65 Billion-159.65%
2014 C$2.76 B13%
2013 C$2.44 B2.46%
2012 C$2.38 B-57.05%
2011 C$5.55 B-10.49%
2010 C$6.21 B-3.99%
2009 C$6.46 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.74 B 681.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.71 B 374.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.57 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.50 B 173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.53 B 130.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$18.09 B 295.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.77 B 201.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.09 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.20 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India